164 results
6-K
EX-99.2
REPCF
Replicel Life Sciences Inc.
13 Aug 21
51-102F3 Material Change Report
12:00am
. Specializing in sales and innovative distribution of consumer health differentiated brands and valued supplements that often utilizes unique technologies … rejuvenation, and RCH-01 for hair restoration. All RepliCel’s cell therapy product candidates are based on RepliCel’s innovative technology, utilizing cell
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
9 Oct 14
RepliCel to Present Commercial and Clinical Update at BioJapan 2014 World Business Forum
12:00am
forward to partnering discussions on our tendon program with companies taking advantage of Japan’s progressive and innovative regulatory process designed … . All product candidates are based on RepliCel’s innovative technology utilizing cell populations isolated from a patient’s own healthy hair follicles
6-K
EX-99.2
REPCF
Replicel Life Sciences Inc.
4 Aug 22
Current report (foreign)
11:41am
to its innovative DermaPrecise™ injector, control unit and consumables,” stated RepliCel President and CEO, R. Lee Buckler. “With the positive results … by a deficit of healthy cells required for normal tissue healing and function. These cell therapy product candidates are based on RepliCel’s innovative
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
9 Sep 14
Replicel Life Sciences Inc. 6-K
12:00am
Exhibit 99.1
NEWS RELEASE
RepliCel Garners Feature on Fox Business News and the Financial Post
RepliCel’s Innovative Technology Converts Your Own … and South Korea. All product candidates are based on RepliCel’s innovative technology utilizing cell populations isolated from a patient’s own healthy hair
6-K
EX-99.2
REPCF
Replicel Life Sciences Inc.
13 Aug 21
RepliCel CEO Provides Corporate Update
12:00am
based in Louisville, Kentucky. Specializing in sales and innovative distribution of consumer health differentiated brands and valued supplements … innovative technology, utilizing cell populations isolated from a patient’s healthy hair follicles. RepliCel's three cell therapy products have now
6-K
EX-99.3
o5kl acwgc2
13 Aug 21
RepliCel CEO Provides Corporate Update
12:00am
6-K
EX-99.1
focu1jv985
29 Aug 19
RepliCel Life Sciences Retains Dermatology Sales and Marketing Executive to Guide the Global Commercial Strategy for its Automated Dermal Injector
11:47am
6-K
EX-99.1
cgrduy00qbnzpa0t0pi
6 Nov 18
RepliCel Life Sciences Appoints Head of Clinical and Regulatory Affairs
11:03am
6-K
EX-99.1
4h2 lbx742qgs
13 Oct 21
RepliCel Life Sciences Appoints One of Japan’s Foremost Regenerative Medicine Industry Business Leaders as Strategic Advisor
12:00am
6-K
EX-99.1
yb109erpnmwwyti8ba
28 Jul 22
Current report (foreign)
2:52pm
6-K
EX-99.1
v1dzmcc
12 Oct 21
RepliCel and University of Victoria Collaboration Leads to Bioengineering Innovations, Funding, and Patents
1:06pm
6-K
EX-99.1
9zxax
18 Oct 18
RepliCel Announces Federal Grant Funding for Collaboration with the University of Victoria, Canada
9:06am
6-K
EX-99.1
nriacpqibiue1ehmcwc
22 May 14
Current report (foreign)
12:00am
6-K
EX-99.1
h2za 761fbgavle8
4 Aug 22
Current report (foreign)
11:41am
6-K
EX-99.1
l1417wraf
12 Nov 20
RepliCel Announces a Binding Term Sheet For Strategic Investment and U.S. Partnership
10:06am
6-K
EX-99.1
bnln6z2frxvyt pzln
3 Feb 21
RepliCel and MainPointe Pharmaceuticals Sign Strategic Investment and Collaboration Agreement
12:03pm
6-K
EX-99
eyqnel3 9em9z
9 Jan 14
RepliCel to Commence Trading on the TSX Venture Exchange
12:00am
6-K
EX-99.1
k2souym
4 Sep 14
RepliCel to Present at Rodman & Renshaw’s 16th Annual
12:00am
6-K
EX-99.1
11p5278kp epdqw
2 Oct 14
Replicel Life Sciences 6-K
12:00am
6-K
EX-99.2
gpryr2mj36hyaax
12 Nov 20
RepliCel Announces a Binding Term Sheet For Strategic Investment and U.S. Partnership
10:06am